Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys

Oyekoya T. Ayonrinde, Leon Adams, Dorota Doherty, Trevor Mori, Lawrence Beilin, Wendy Oddy, M. Hickey, D.M. Sloboda, J.K. Olynyk, Roger Hart

Research output: Contribution to journalArticle

13 Citations (Scopus)
214 Downloads (Pure)

Abstract

© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. Background and Aims:: Non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) share risk associations of adiposity and insulin resistance. We examined the impact of a PCOS diagnosis on the metabolic phenotype of adolescent girls with NAFLD and compared this to girls without PCOS or NAFLD and to age-matched boys. Methods:: Community-based adolescents from the Raine Cohort participated in assessments for NAFLD (572 girls and 592 boys) and PCOS (244 girls). One hundred and ninety-nine girls attended both assessments. Results:: Amongst the 199 girls, PCOS was diagnosed in 16.1% and NAFLD in 18.6%. NAFLD was diagnosed in 10.1% of the boys. NAFLD was more prevalent in girls with PCOS than girls without PCOS (37.5% vs 15.1%, P=0.003). Girls with NAFLD plus PCOS had greater adiposity (waist circumference, body mass index, suprailiac skinfold thickness [SST], serum androgens, high-sensitivity C-reactive protein, ferritin, homeostasis model assessment for insulin resistance (HOMA-IR), and lower serum sex hormone binding globulin levels than girls with NAFLD without a PCOS diagnosis (all P
Original languageEnglish
Pages (from-to)980-987
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume31
Issue number5
DOIs
Publication statusPublished - May 2016

Fingerprint

Polycystic Ovary Syndrome
Phenotype
Adiposity
Gastroenterology
Insulin Resistance
Non-alcoholic Fatty Liver Disease
Serum Globulins
Skinfold Thickness
Sex Hormone-Binding Globulin
Waist Circumference
Ferritins
Nuclear Family
C-Reactive Protein
Androgens
Body Mass Index
Homeostasis

Cite this

@article{18bc5539c8d944c980f1feda71a360be,
title = "Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys",
abstract = "{\circledC} 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. Background and Aims:: Non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) share risk associations of adiposity and insulin resistance. We examined the impact of a PCOS diagnosis on the metabolic phenotype of adolescent girls with NAFLD and compared this to girls without PCOS or NAFLD and to age-matched boys. Methods:: Community-based adolescents from the Raine Cohort participated in assessments for NAFLD (572 girls and 592 boys) and PCOS (244 girls). One hundred and ninety-nine girls attended both assessments. Results:: Amongst the 199 girls, PCOS was diagnosed in 16.1{\%} and NAFLD in 18.6{\%}. NAFLD was diagnosed in 10.1{\%} of the boys. NAFLD was more prevalent in girls with PCOS than girls without PCOS (37.5{\%} vs 15.1{\%}, P=0.003). Girls with NAFLD plus PCOS had greater adiposity (waist circumference, body mass index, suprailiac skinfold thickness [SST], serum androgens, high-sensitivity C-reactive protein, ferritin, homeostasis model assessment for insulin resistance (HOMA-IR), and lower serum sex hormone binding globulin levels than girls with NAFLD without a PCOS diagnosis (all P",
author = "Ayonrinde, {Oyekoya T.} and Leon Adams and Dorota Doherty and Trevor Mori and Lawrence Beilin and Wendy Oddy and M. Hickey and D.M. Sloboda and J.K. Olynyk and Roger Hart",
year = "2016",
month = "5",
doi = "10.1111/jgh.13241",
language = "English",
volume = "31",
pages = "980--987",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "John Wiley & Sons",
number = "5",

}

TY - JOUR

T1 - Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys

AU - Ayonrinde, Oyekoya T.

AU - Adams, Leon

AU - Doherty, Dorota

AU - Mori, Trevor

AU - Beilin, Lawrence

AU - Oddy, Wendy

AU - Hickey, M.

AU - Sloboda, D.M.

AU - Olynyk, J.K.

AU - Hart, Roger

PY - 2016/5

Y1 - 2016/5

N2 - © 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. Background and Aims:: Non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) share risk associations of adiposity and insulin resistance. We examined the impact of a PCOS diagnosis on the metabolic phenotype of adolescent girls with NAFLD and compared this to girls without PCOS or NAFLD and to age-matched boys. Methods:: Community-based adolescents from the Raine Cohort participated in assessments for NAFLD (572 girls and 592 boys) and PCOS (244 girls). One hundred and ninety-nine girls attended both assessments. Results:: Amongst the 199 girls, PCOS was diagnosed in 16.1% and NAFLD in 18.6%. NAFLD was diagnosed in 10.1% of the boys. NAFLD was more prevalent in girls with PCOS than girls without PCOS (37.5% vs 15.1%, P=0.003). Girls with NAFLD plus PCOS had greater adiposity (waist circumference, body mass index, suprailiac skinfold thickness [SST], serum androgens, high-sensitivity C-reactive protein, ferritin, homeostasis model assessment for insulin resistance (HOMA-IR), and lower serum sex hormone binding globulin levels than girls with NAFLD without a PCOS diagnosis (all P

AB - © 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. Background and Aims:: Non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) share risk associations of adiposity and insulin resistance. We examined the impact of a PCOS diagnosis on the metabolic phenotype of adolescent girls with NAFLD and compared this to girls without PCOS or NAFLD and to age-matched boys. Methods:: Community-based adolescents from the Raine Cohort participated in assessments for NAFLD (572 girls and 592 boys) and PCOS (244 girls). One hundred and ninety-nine girls attended both assessments. Results:: Amongst the 199 girls, PCOS was diagnosed in 16.1% and NAFLD in 18.6%. NAFLD was diagnosed in 10.1% of the boys. NAFLD was more prevalent in girls with PCOS than girls without PCOS (37.5% vs 15.1%, P=0.003). Girls with NAFLD plus PCOS had greater adiposity (waist circumference, body mass index, suprailiac skinfold thickness [SST], serum androgens, high-sensitivity C-reactive protein, ferritin, homeostasis model assessment for insulin resistance (HOMA-IR), and lower serum sex hormone binding globulin levels than girls with NAFLD without a PCOS diagnosis (all P

U2 - 10.1111/jgh.13241

DO - 10.1111/jgh.13241

M3 - Article

VL - 31

SP - 980

EP - 987

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 5

ER -